CoChat
Sign Up
Cited by 248

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

The emerging roles of microRNAs in CNS injuries

Bhalala, Oneil G., Srikanth, Maya, Kessler, John A.·2013·Nature Reviews Neurology
DOI 10.1038/nrneurol.2013.67PMC PMC3755895
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2013.67

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 130

  1. Coronado, V. G. et al. Surveillance for traumatic brain injury-related deaths—United States, 1997–2007. MMWR Surveill. Summ. 60, 1–32 (2011).
  2. Munro, K. M. & Perreau, V. M. Current and future applications of transcriptomics for discovery in CNS disease and injury. Neurosignals 17, 311–327 (2009). · DOI
  3. Qureshi, I. A. & Mehler, M. F. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat. Rev. Neurosci. 13, 528–541 (2012). · DOI
  4. Salta, E. & De Strooper, B. Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol. 11, 189–200 (2012). · DOI
  5. Carthew, R. W. & Sontheimer, E. J. Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642–655 (2009). · DOI
  6. Bian, S. & Sun, T. Functions of noncoding RNAs in neural development and neurological diseases. Mol. Neurobiol. 44, 359–373 (2011). · DOI
  7. Meza-Sosa, K. F., Valle-García, D., Pedraza-Alva, G. & Pérez-Martínez, L. Role of microRNAs in central nervous system development and pathology. J. Neurosci. Res. 90, 1–12 (2012). · DOI
  8. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004). · DOI
  9. Lee, Y., Jeon, K., Lee, J. T., Kim, S. & Kim, V. N. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663–4670 (2002). · DOI
  10. Zeng, Y. & Cullen, B. R. Sequence requirements for micro RNA processing and function in human cells. RNA 9, 112–123 (2003). · DOI
  11. Basyuk, E., Suavet, F., Doglio, A., Bordonné, R. & Bertrand, E. Human let-7 stem-loop precursors harbor features of RNase III cleavage products. Nucleic Acids Res. 31, 6593–6597 (2003). · DOI
  12. Han, J. et al. The Drosha–DGCR8 complex in primary microRNA processing. Genes Dev. 18, 3016–3027 (2004). · DOI
  13. Lau, N. C., Lim, L. P., Weinstein, E. G. & Bartel, D. P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858–862 (2001). · DOI · Paper page
  14. Hutvágner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838 (2001). · DOI · Paper page
  15. Chendrimada, T. P. et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740–744 (2005). · DOI
  16. Long, J. M. & Lahiri, D. K. Advances in microRNA experimental approaches to study physiological regulation of gene products implicated in CNS disorders. Exp. Neurol. 235, 402–418 (2012). · DOI
  17. Nass, D. et al. miR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol. 19, 375–383 (2009). · DOI
  18. Hammond, S. M., Bernstein, E., Beach, D. & Hannon, G. J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404, 293–296 (2000). · DOI
  19. Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R. & Tuschl, T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563–574 (2002). · DOI
  20. Peters, L. & Meister, G. Argonaute proteins: mediators of RNA silencing. Mol. Cell 26, 611–623 (2007). · DOI · Paper page
  21. Fabian, M. R. & Sonenberg, N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19, 586–593 (2012). · DOI
  22. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840 (2010). · DOI · Paper page
  23. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell 115, 787–798 (2003). · DOI · Paper page
  24. Esquela-Kerscher, A. & Slack, F. J. Oncomirs—microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259–269 (2006). · DOI · Paper page
  25. Sandberg, R., Neilson, J. R., Sarma, A., Sharp, P. A. & Burge, C. B. Proliferating cells express mRNAs with shortened 3′ untranslated regions and fewer microRNA target sites. Science 320, 1643–1647 (2008). · DOI · Paper page
  26. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 294, 853–858 (2001). · DOI · Paper page
  27. Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A. & Tuschl, T. New microRNAs from mouse and human. RNA 9, 175–179 (2003). · DOI · Paper page
  28. Lagos-Quintana, M. et al. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735–739 (2002). · DOI · Paper page
  29. Lee, R. C. & Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294, 862–864 (2001). · DOI · Paper page
  30. Bernstein, E. et al. Dicer is essential for mouse development. Nat. Genet. 35, 215–217 (2003). · DOI · Paper page
  31. De Pietri Tonelli, D. et al. miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex. Development 135, 3911–3921 (2008). · DOI · Paper page
  32. Davis, T. H. et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 28, 4322–4330 (2008). · DOI · Paper page
  33. Liu, J. et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437–1441 (2004). · DOI · Paper page
  34. Miska, E. A. et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol. 5, R68 (2004). · DOI · Paper page
  35. Smith, B. et al. Large-scale expression analysis reveals distinct microRNA profiles at different stages of human neurodevelopment. PLoS ONE 5, e11109 (2010). · DOI
  36. Zheng, K., Li, H., Zhu, Y., Zhu, Q. & Qiu, M. MicroRNAs are essential for the developmental switch from neurogenesis to gliogenesis in the developing spinal cord. J. Neurosci. 30, 8245–8250 (2010). · DOI
  37. Li, Y., Wang, F., Lee, J. A. & Gao, F. B. MicroRNA-9a ensures the precise specification of sensory organ precursors in Drosophila. Genes Dev. 20, 2793–2805 (2006). · DOI · Paper page
  38. Zhao, C., Sun, G., Li, S. & Shi, Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 16, 365–371 (2009). · DOI · Paper page
  39. Cheng, L. C., Pastrana, E., Tavazoie, M. & Doetsch, F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 12, 399–408 (2009). · DOI · Paper page
  40. Liu, X. S. et al. MicroRNA profiling in subventricular zone after stroke: miR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway. PLoS ONE 6, e23461 (2011). · DOI
  41. He, X., Yu, Y., Awatramani, R. & Lu, Q. R. Unwrapping myelination by microRNAs. Neuroscientist 18, 45–55 (2012). · DOI
  42. Dugas, J. C. et al. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron 65, 597–611 (2010). · DOI · Paper page
  43. Zhao, X. et al. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65, 612–626 (2010). · DOI · Paper page
  44. Budde, H. et al. Control of oligodendroglial cell number by the miR-17-92 cluster. Development 137, 2127–2132 (2010). · DOI · Paper page
  45. Sahni, V. et al. BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. J. Neurosci. 30, 1839–1855 (2010). · DOI
  46. Zheng, K., Li, H., Huang, H. & Qiu, M. MicroRNAs and glial cell development. Neuroscientist 18, 114–118 (2012). · DOI
  47. Tao, J. et al. Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci. 31, 8306–8319 (2011). · DOI
  48. Ackery, A., Tator, C. & Krassioukov, A. A global perspective on spinal cord injury epidemiology. J. Neurotrauma 21, 1355–1370 (2004). · DOI
  49. Liu, N. K., Wang, X. F., Lu, Q. B. & Xu, X. M. Altered microRNA expression following traumatic spinal cord injury. Exp. Neurol. 219, 424–429 (2009). · DOI · Paper page
  50. Yunta, M. et al. MicroRNA dysregulation in the spinal cord following traumatic injury. PLoS ONE 7, e34534 (2012). · DOI · Paper page
  51. De Biase, A. et al. Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. Physiol. Genomics 22, 368–381 (2005). · DOI
  52. Strickland, E. R. et al. MicroRNA dysregulation following spinal cord contusion: implications for neural plasticity and repair. Neuroscience 186, 146–160 (2011). · DOI · Paper page
  53. Wu, J. et al. miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle 9, 1809–1818 (2010). · DOI
  54. Jee, M. K., Jung, J. S., Im, Y. B., Jung, S. J. & Kang, S. K. Silencing of miR20a is crucial for Ngn1-mediated neuroprotection in injured spinal cord. Hum. Gene Ther. 23, 508–520 (2012). · DOI
  55. Bertrand, N., Castro, D. S. & Guillemot, F. Proneural genes and the specification of neural cell types. Nat. Rev. Neurosci. 3, 517–530 (2002). · DOI
  56. Carraro, G. et al. miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. Dev. Biol. 333, 238–250 (2009). · DOI
  57. Yan, H. et al. MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. Hum. Gene Ther. 21, 1723–1734 (2010). · DOI
  58. Jee, M. K. et al. MicroRNA 486 is a potentially novel target for the treatment of spinal cord injury. Brain 135, 1237–1252 (2012). · DOI · Paper page
  59. Uittenbogaard, M., Baxter, K. K. & Chiaramello, A. The neurogenic basic helix-loop-helix transcription factor NeuroD6 confers tolerance to oxidative stress by triggering an antioxidant response and sustaining the mitochondrial biomass. ASN Neuro 2, e00034 (2010). · DOI
  60. Liu, G., Detloff, M. R., Miller, K. N., Santi, L. & Houlé, J. D. Exercise modulates microRNAs that affect the PTEN/mTOR pathway in rats after spinal cord injury. Exp. Neurol. 233, 447–456 (2012). · DOI
  61. Bhalala, O. G. et al. microRNA-21 regulates astrocytic response following spinal cord injury. J. Neurosci. 32, 17935–17947 (2012). · DOI · Paper page
  62. Chan, J. A., Krichevsky, A. M. & Kosik, K. S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65, 6029–6033 (2005). · DOI · Paper page
  63. Ciafrè, S. A. et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 334, 1351–1358 (2005). · DOI · Paper page
  64. Volinia, S. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA 103, 2257–2261 (2006). · DOI · Paper page
  65. van Rooij, E. et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl Acad. Sci. USA 103, 18255–18260 (2006). · DOI
  66. Fawcett, J. W. & Asher, R. A. The glial scar and central nervous system repair. Brain Res. Bull. 49, 377–391 (1999). · DOI
  67. Barnabé-Heider, F. & Frisén, J. Stem cells for spinal cord repair. Cell Stem Cell 3, 16–24 (2008). · DOI
  68. Sofroniew, M. V. Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400–407 (2005). · DOI
  69. Davis, B. N., Hilyard, A. C., Lagna, G. & Hata, A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56–61 (2008). · DOI
  70. van den Brand, R. et al. Restoring voluntary control of locomotion after paralyzing spinal cord injury. Science 336, 1182–1185 (2012). · DOI · Paper page
  71. Liu, G., Keeler, B. E., Zhukareva, V. & Houlé, J. D. Cycling exercise affects the expression of apoptosis-associated microRNAs after spinal cord injury in rats. Exp. Neurol. 226, 200–206 (2010). · DOI
  72. Liu, K. et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 13, 1075–1081 (2010). · DOI
  73. Shively, S. B. & Perl, D. P. Traumatic brain injury, shell shock, and posttraumatic stress disorder in the military—past, present, and future. J. Head Trauma Rehabil. 27, 234–239 (2012). · DOI
  74. Lei, P., Li, Y., Chen, X., Yang, S. & Zhang, J. Microarray based analysis of microRNA expression in rat cerebral cortex after traumatic brain injury. Brain Res. 1284, 191–201 (2009). · DOI · Paper page
  75. Orrison, W. W. et al. Traumatic brain injury: a review and high-field MRI findings in 100 unarmed combatants using a literature-based checklist approach. J. Neurotrauma 26, 689–701 (2009). · DOI
  76. Cohen, A. S. et al. Injury-induced alterations in CNS electrophysiology. Prog. Brain Res. 161, 143–169 (2007). · DOI
  77. Redell, J. B., Liu, Y. & Dash, P. K. Traumatic brain injury alters expression of hippocampal microRNAs: potential regulators of multiple pathophysiological processes. J. Neurosci. Res. 87, 1435–1448 (2009). · DOI · Paper page
  78. Hu, Z. et al. Expression of miRNAs and their cooperative regulation of the pathophysiology in traumatic brain injury. PLoS ONE 7, e39357 (2012). · DOI
  79. Redell, J. B., Zhao, J. & Dash, P. K. Altered expression of miRNA-21 and its targets in the hippocampus after traumatic brain injury. J. Neurosci. Res. 89, 212–221 (2011). · DOI
  80. Balakathiresan, N. et al. MicroRNA let-7i is a promising serum biomarker for blast-induced traumatic brain injury. J. Neurotrauma 29, 1379–1387 (2012). · DOI · Paper page
  81. Geyer, C., Ulrich, A., Gräfe, G., Stach, B. & Till, H. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. J. Neurosurg. Pediatr. 4, 339–344 (2009). · DOI
  82. Papa, L. et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit. Care Med. 38, 138–144 (2010). · DOI
  83. Svetlov, S. I. et al. Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. J. Trauma 69, 795–804 (2010). · DOI
  84. Redell, J. B., Moore, A. N., Ward, N. H. 3rd, Hergenroeder, G. W. & Dash, P. K. Human traumatic brain injury alters plasma microRNA levels. J. Neurotrauma 27, 2147–2156 (2010). · DOI
  85. Marion, D. & Bullock, M. R. Current and future role of therapeutic hypothermia. J. Neurotrauma 26, 455–467 (2009). · DOI
  86. Dietrich, W. D., Atkins, C. M. & Bramlett, H. M. Protection in animal models of brain and spinal cord injury with mild to moderate hypothermia. J. Neurotrauma 26, 301–312 (2009). · DOI
  87. Choi, H. A., Badjatia, N. & Mayer, S. A. Hypothermia for acute brain injury—mechanisms and practical aspects. Nat. Rev. Neurol. 8, 214–222 (2012). · DOI
  88. Truettner, J. S., Alonso, O. F., Bramlett, H. M. & Dietrich, W. D. Therapeutic hypothermia alters microRNA responses to traumatic brain injury in rats. J. Cereb. Blood Flow Metab. 31, 1897–1907 (2011). · DOI
  89. Bushnell, C. D. Stroke and the female brain. Nat. Clin. Pract. Neurol. 4, 22–33 (2008). · DOI
  90. Tan, K. S. et al. Expression profile of MicroRNAs in young stroke patients. PLoS ONE 4, e7689 (2009). · DOI
  91. Liu, D. Z. et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 30, 92–101 (2010). · DOI
  92. Badaut, J., Lasbennes, F., Magistretti, P. J. & Regli, L. Aquaporins in brain: distribution, physiology, and pathophysiology. J. Cereb. Blood Flow Metab. 22, 367–378 (2002). · DOI
  93. Manley, G. T. et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat. Med. 6, 159–163 (2000). · DOI
  94. Papadopoulos, M. C., Manley, G. T., Krishna, S. & Verkman, A. S. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 18, 1291–1293 (2004). · DOI
  95. Jeyaseelan, K., Lim, K. Y. & Armugam, A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke 39, 959–966 (2008). · DOI
  96. Sepramaniam, S. et al. MicroRNA 320a functions as a novel endogenous modulator of aquaporins 1 and 4 as well as a potential therapeutic target in cerebral ischemia. J. Biol. Chem. 285, 29223–29230 (2010). · DOI
  97. Yin, K. J. et al. miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia. Neurobiol. Dis. 38, 17–26 (2010). · DOI
  98. Shi, G. et al. Upregulated miR-29b promotes neuronal cell death by inhibiting Bcl2L2 after ischemic brain injury. Exp. Brain Res. 216, 225–230 (2012). · DOI
  99. Dharap, A., Bowen, K., Place, R., Li, L. C. & Vemuganti, R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J. Cereb. Blood Flow Metab. 29, 675–687 (2009). · DOI
  100. Eltzschig, H. K. & Eckle, T. Ischemia and reperfusion—from mechanism to translation. Nat. Med. 17, 1391–1401 (2011). · DOI
  101. Dharap, A. & Vemuganti, R. Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J. Neurochem. 113, 1685–1691 (2010). · DOI
  102. Lee, S. T. et al. MicroRNAs induced during ischemic preconditioning. Stroke 41, 1646–1651 (2010). · DOI
  103. Lusardi, T. A. et al. Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab. 30, 744–756 (2010). · DOI
  104. Stenzel-Poore, M. P. et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362, 1028–1037 (2003). · DOI
  105. Ziu, M., Fletcher, L., Rana, S., Jimenez, D. F. & Digicaylioglu, M. Temporal differences in microRNA expression patterns in astrocytes and neurons after ischemic injury. PLoS ONE 6, e14724 (2011). · DOI
  106. Shih, J. D., Waks, Z., Kedersha, N. & Silver, P. A. Visualization of single mRNAs reveals temporal association of proteins with microRNA-regulated mRNA. Nucleic Acids Res. 39, 7740–7749 (2011). · DOI
  107. Judge, A. D. et al. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457–462 (2005). · DOI
  108. Peacock, H. et al. Nucleobase and ribose modifications control immunostimulation by a microRNA-122-mimetic RNA. J. Am. Chem. Soc. 133, 9200–9203 (2011). · DOI
  109. Akao, Y. et al. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 17, 398–408 (2010). · DOI
  110. Pereira, D. M., Rodrigues, P. M., Borralho, P. M. & Rodrigues, C. M. Delivering the promise of miRNA cancer therapeutics. Drug Discov. Today 18, 282–289 (2012). · DOI
  111. Ouyang, Y. B. et al. miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo. Neurobiol. Dis. 45, 555–563 (2012). · DOI
  112. Lee, S. T. et al. Altered microRNA regulation in Huntington's disease models. Exp. Neurol. 227, 172–179 (2011). · DOI · Paper page
  113. Krützfeldt, J. et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 35, 2885–2892 (2007). · DOI
  114. Broderick, J. A. & Zamore, P. D. MicroRNA therapeutics. Gene Ther. 18, 1104–1110 (2011). · DOI
  115. Grünweller, A. & Hartmann, R. K. Locked nucleic acid oligonucleotides: the next generation of antisense agents? BioDrugs 21, 235–243 (2007). · DOI
  116. Stenvang, J., Silahtaroglu, A. N., Lindow, M., Elmen, J. & Kauppinen, S. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin. Cancer Biol. 18, 89–102 (2008). · DOI
  117. Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896–899 (2008). · DOI · Paper page
  118. Elmen, J. et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36, 1153–1162 (2008). · DOI
  119. Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198–201 (2010). · DOI · Paper page
  120. Elmen, J. et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 33, 439–447 (2005). · DOI
  121. Wang, H. et al. Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity. Mol. Pharm. 9, 1638–1644 (2012). · DOI
  122. Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721–726 (2007). · DOI · Paper page
  123. Gentner, B. et al. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 6, 63–66 (2009). · DOI
  124. Schorey, J. S. & Bhatnagar, S. Exosome function: from tumor immunology to pathogen biology. Traffic 9, 871–881 (2008). · DOI
  125. Simpson, R. J., Jensen, S. S. & Lim, J. W. Proteomic profiling of exosomes: current perspectives. Proteomics 8, 4083–4099 (2008). · DOI
  126. Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341–345 (2011). · DOI · Paper page
  127. Kotipatruni, R. R. et al. p53- and Bax-mediated apoptosis in injured rat spinal cord. Neurochem. Res. 36, 2063–2074 (2011). · DOI
  128. Nagel, S. et al. Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia. Neuroscience 208, 109–122 (2012). · DOI
  129. Zeng, Y., Wagner, E. J. & Cullen, B. R. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 9, 1327–1333 (2002). · DOI
  130. De Guire, V. et al. Designing small multiple-target artificial RNAs. Nucleic Acids Res. 38, e140 (2010). · DOI

Cited by

Sorted by citations

Metadata

Authors
Bhalala, O. G., Srikanth, M., & Kessler, J. A.
Venue
Nature Reviews Neurology
Publisher
Springer Science and Business Media LLC
Published
2013-04-16
Volume
9
Issue
6
Pages
328-339
ISSN
  • 1759-4758
  • 1759-4766
DOI
10.1038/nrneurol.2013.67
PMC
PMC3755895
Cited by
248
References
10
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review